1Turesson C, BergstrSm U, Jacobsson LT, et al. Increased carti- lage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann Rheum Dis, 2011,70 (3):520-522.
2Mansour HE, Metwaly KM, Hassan IA, et al. Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diag- nostic Value, Association with Radiological Damage and Axial Skeleton Affection. Clin Med Insights Arthritis Musculoskelet Disord, 2010, 24(3) : 33-42.
3Liew FY, Pitman NI, Mclnnes IB. Disease-associated func- tions of IL-33:the new kid in the IL-1 family. Nat Rev Im- munol, 2010, 10(2):103-110.
4Paimer G, Taiabot-Ayer D, Lamacchia C, et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum, 2009, 60(3) : 738-749.
5Leung BP,Xu D,Culshaw S,et al.A novel therapy of murine colla-gen-induced arthritis with soluble Tl,'SrI2.Immunol, 2004, 173( 1 ) : 145-150.
6Verri W J, Souto F, Vieira SM, et al.IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy.Ann Rheum Dis, 2010,69(9):1697-1703.
7Niedbala W,Wei XQ,Cai B,et al.IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Thl7 cells.Immunology, 2007,37( 11 ) : 3021-3029.
8Pate1 S, Farragher T,Berry J,et al.Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis.Arthritis Rheum,2007,56(7): 2143-2149.
9Maalej A,Petit TE,Michou L, et al.Association study of VDR gene with rheumatoid arthritis in the French population.Genes Immun,2005,6(8) :707-711.
10Gomez VC,Fiter J,Enjuanes A ,et al.Influence of the BsmI polymorphism of the vitamin D receptor gene on rheumatoid arthritis clinical activity.J Rheumatol,2007 ,34 (9):1823- 1826.
